Can a current dengue infection and a past infection from a year ago result in a positive antigen and Immunoglobulin G (IgG) test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dengue Diagnostic Interpretation: Current and Past Infections

Yes, it is possible to have both a positive dengue antigen and IgG if you currently have dengue infection and also had it a year ago. 1, 2

Understanding Dengue Diagnostic Markers

The interpretation of dengue diagnostic tests depends on the timing of the specimen collection and the patient's infection history:

Acute Phase Markers (≤7 days after symptom onset):

  • NS1 Antigen: Detectable from day 1 of fever onset 2
  • Viral RNA: Detectable by NAAT (nucleic acid amplification test) 1
  • IgM antibodies: Begin to appear 3-5 days after onset 1
  • IgG antibodies:
    • In primary infections: Appear later, usually after day 7
    • In secondary infections: Can rise rapidly within 1-2 days 1, 2

Convalescent Phase Markers (>7 days after symptom onset):

  • IgM antibodies: Peak around 2 weeks and can persist for 2-3 months 1
  • IgG antibodies: Rise more slowly in primary infections, rapidly in secondary infections 1

Interpretation of Your Scenario

In your specific scenario (current infection + previous infection from a year ago):

  1. Positive NS1 antigen: Indicates current active dengue virus replication 2

  2. Positive IgG: Can be explained by:

    • Previous dengue infection from a year ago (IgG can persist for years) 1
    • Early secondary immune response if this is indeed a second infection 1, 3

This pattern (positive antigen + positive IgG) is consistent with a secondary dengue infection in someone previously exposed to dengue virus 1, 4.

Clinical Implications

The presence of both markers has important clinical implications:

  • Increased risk of severe disease: Secondary dengue infections are associated with higher risk of severe manifestations 4
  • Triple positivity warning: If NS1, IgM, and IgG are all positive, this pattern has been associated with increased risk of severe thrombocytopenia 4
  • Monitoring requirements: Patients with secondary infections require closer monitoring for warning signs of severe dengue 2

Diagnostic Algorithm

To confirm this interpretation:

  1. If within 7 days of symptom onset:

    • Positive dengue NS1 antigen + positive IgG = likely secondary dengue infection 1
    • Consider NAAT testing to confirm active infection if available 1
  2. If beyond 7 days of symptom onset:

    • Test for both IgM and IgG antibodies 1
    • Consider PRNT (plaque reduction neutralization test) if available to confirm specific flavivirus infection 1

Common Pitfalls to Avoid

  • Cross-reactivity: IgG antibodies may cross-react with other flaviviruses (like Zika, Japanese encephalitis) 1, 5
  • Misinterpreting timing: The presence of IgG alone doesn't distinguish between current and past infections without additional markers 1
  • Overlooking severity risk: Secondary dengue infections can progress more rapidly to severe disease 2, 4

Remember that while a positive antigen indicates current infection, the presence of IgG without considering other markers and clinical context cannot definitively distinguish between primary and secondary dengue infections 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Dengue Fever Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Triple positivity for nonstructural antigen 1, immunoglobulin M and immunoglobulin G is predictive of severe thrombocytopaenia related to dengue infection.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.